275 related articles for article (PubMed ID: 27128108)
21. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis.
Fan S; Xu Y; Ren H; Guan H; Feng F; Gao X; Ding D; Fang F; Shan G; Guan T; Zhang Y; Dai Y; Yao M; Peng B; Zhu Y; Cui L
Mult Scler Relat Disord; 2018 Feb; 20():144-152. PubMed ID: 29414288
[TBL] [Abstract][Full Text] [Related]
22. Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.
Jurynczyk M; Geraldes R; Probert F; Woodhall MR; Waters P; Tackley G; DeLuca G; Chandratre S; Leite MI; Vincent A; Palace J
Brain; 2017 Mar; 140(3):617-627. PubMed ID: 28364548
[TBL] [Abstract][Full Text] [Related]
23. The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients.
Siritho S; Sato DK; Kaneko K; Fujihara K; Prayoonwiwat N
Mult Scler; 2016 Jun; 22(7):964-8. PubMed ID: 26498263
[TBL] [Abstract][Full Text] [Related]
24. Clinical and radiologic approach to 'typical' versus antibody-related optic neuritis.
Caron-Cantin M; Cestari DM; Fortin E
Curr Opin Ophthalmol; 2019 Nov; 30(6):412-417. PubMed ID: 31503075
[TBL] [Abstract][Full Text] [Related]
25. Quantitative brain lesion distribution may distinguish MOG-ab and AQP4-ab neuromyelitis optica spectrum disorders.
Yang L; Li H; Xia W; Quan C; Zhou L; Geng D; Li Y
Eur Radiol; 2020 Mar; 30(3):1470-1479. PubMed ID: 31748853
[TBL] [Abstract][Full Text] [Related]
26. Correlations among disability, anti-AQP4 antibody status and prognosis in the spinal cord involved patients with NMOSD.
Hsu JL; Liao MF; Chang KH; Cheng MY; Ro LS
BMC Neurol; 2021 Apr; 21(1):153. PubMed ID: 33836682
[TBL] [Abstract][Full Text] [Related]
27. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
Sato DK; Callegaro D; Lana-Peixoto MA; Waters PJ; de Haidar Jorge FM; Takahashi T; Nakashima I; Apostolos-Pereira SL; Talim N; Simm RF; Lino AM; Misu T; Leite MI; Aoki M; Fujihara K
Neurology; 2014 Feb; 82(6):474-81. PubMed ID: 24415568
[TBL] [Abstract][Full Text] [Related]
28. Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations.
Juryńczyk M; Jacob A; Fujihara K; Palace J
Pract Neurol; 2019 Jun; 19(3):187-195. PubMed ID: 30530724
[TBL] [Abstract][Full Text] [Related]
29. What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM).
Carnero Contentti E; Lopez PA; Pettinicchi JP; Pappolla A; Miguez J; Patrucco L; Cristiano E; Vrech C; Tkachuk V; Liwacki S; Correale J; Marrodan M; Gaitán MI; Fiol M; Negrotto L; Ysrraelit MC; Burgos M; Leguizamon F; Tavolini D; Deri N; Balbuena ME; Mainella C; Luetic G; Blaya P; Hryb J; Menichini ML; Alvez Pinheiro A; Nofal P; Zanga G; Barboza A; Martos I; Lazaro L; Alonso R; Silva E; Bestoso S; Fracaro ME; Carrá A; Garcea O; Fernandez Liguori N; Alonso Serena M; Caride A; Rojas JI
Mult Scler Relat Disord; 2021 Apr; 49():102742. PubMed ID: 33454601
[TBL] [Abstract][Full Text] [Related]
30. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.
van Pelt ED; Wong YY; Ketelslegers IA; Hamann D; Hintzen RQ
Eur J Neurol; 2016 Mar; 23(3):580-7. PubMed ID: 26593750
[TBL] [Abstract][Full Text] [Related]
31. Neuromyelitis Optica Spectrum Disorders.
Akaishi T; Nakashima I; Sato DK; Takahashi T; Fujihara K
Neuroimaging Clin N Am; 2017 May; 27(2):251-265. PubMed ID: 28391784
[TBL] [Abstract][Full Text] [Related]
32. The clinical value of the albumin quotient in patients with neuromyelitis optica spectrum disorder.
Chen B; Qin C; Tao R; Dong YJ; Ma X; Chen M; Wu LJ; Bu BT; Tian DS
Mult Scler Relat Disord; 2020 Feb; 38():101880. PubMed ID: 31812873
[TBL] [Abstract][Full Text] [Related]
33. Update on pediatric optic neuritis.
Lock JH; Newman NJ; Biousse V; Peragallo JH
Curr Opin Ophthalmol; 2019 Nov; 30(6):418-425. PubMed ID: 31433309
[TBL] [Abstract][Full Text] [Related]
34. Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD.
Arru G; Sechi E; Mariotto S; Zarbo IR; Ferrari S; Gajofatto A; Monaco S; Deiana GA; Bo M; Sechi LA; Sechi GP
J Neuroimmunol; 2020 Jan; 338():577110. PubMed ID: 31715457
[TBL] [Abstract][Full Text] [Related]
35. Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
Kim SM; Waters P; Woodhall M; Kim JY; Kim JE; Yang JW; Kim JS; Sung JJ; Park KS; Lee KW
Mult Scler; 2013 Jul; 19(8):1060-7. PubMed ID: 23329699
[TBL] [Abstract][Full Text] [Related]
36. [Diagnostic criteria and differential diagnosis of neuromyelitis optica].
Nakashima I
Nihon Rinsho; 2014 Nov; 72(11):1964-9. PubMed ID: 25518378
[TBL] [Abstract][Full Text] [Related]
37. Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
Jurynczyk M; Probert F; Yeo T; Tackley G; Claridge TDW; Cavey A; Woodhall MR; Arora S; Winkler T; Schiffer E; Vincent A; DeLuca G; Sibson NR; Isabel Leite M; Waters P; Anthony DC; Palace J
Acta Neuropathol Commun; 2017 Dec; 5(1):95. PubMed ID: 29208041
[TBL] [Abstract][Full Text] [Related]
38. Clinical and MRI phenotype of children with MOG antibodies.
Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
[TBL] [Abstract][Full Text] [Related]
39. [Clinical concept, etiology and pathology of neuromyelitis optica].
Kurosawa K; Fujihara K
Nihon Rinsho; 2014 Nov; 72(11):1897-902. PubMed ID: 25518368
[TBL] [Abstract][Full Text] [Related]
40. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.
Rostásy K; Mader S; Hennes EM; Schanda K; Gredler V; Guenther A; Blaschek A; Korenke C; Pritsch M; Pohl D; Maier O; Kuchukhidze G; Brunner-Krainz M; Berger T; Reindl M
Mult Scler; 2013 Jul; 19(8):1052-9. PubMed ID: 23257621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
